A phenolic acid phenethyl urea compound inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines in cell culture

International Immunopharmacology

Volumn 10, Issue 4, 2010, Pages 526-532

  Hwang, Jung Min ^a   Yu, Ji Yeon ^a   Jang, Young Oh ^b   Kim, Beom Tae ^a   Hwang, Ki Jun ^a   Jeon, Young Mi ^a   Lee, Jeong Chae ^a  

^a Chonbuk National University   (South Korea)

^b Korea Minjok Leadership Academy   (South Korea)

Author keywords

(E) 1 (3,4 dihydroxystyryl) 3 (4 hydroxyphenetyl)urea; Anti inflammation; Cytokines; Extracellular signal regulated kinase; Nitric oxide; Nuclear factor B

Indexed keywords

1 (3,4 DIHYDROXYSTYRYL) 3 (4 HYDROXYPHENETHYL)UREA (DSHP U); CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PHENOL DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; BONE MARROW CELLS; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PERIODONTIUM; STYRENES; UREA;

EID: 77949656491     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.01.016     Document Type: Article

References (36)

1. Kern T.S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res (2007) 95103-95116
2. Hesslinger C., Strub A., Boer R., Ulrich W.R., Lehner M.D., and Braun C. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 37 (2009) 886-891
3. Kanwar J.R., Kanwar R.K., Burrow H., and Baratchi S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Cur Med Chem 16 (2009) 2373-2394
4. Sung C.S., and Wong C.S. Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1beta. Acta Anaesthesiol Taiwan 45 (2007) 103-109
5. Vuolteenaho K., Moilanen T., Knowles R.G., and Moilanen E. The role of nitric oxide in osteoarthritis. Scand J Rheumatol 36 (2007) 247-258
6. de la Lastra C.A., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49 (2005) 405-430
7. Vafeiadou K., Vauzour D., and Spencer J.P. Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets 7 (2007) 211-224
8. Lee M.Y., Park B.Y., Kwon O.K., Yuk J.E., Oh S.R., Kim H.S., et al. Anti-inflammatory activity of (-)-aptosimon isolated from Daphne genkwa in RAW264.7 cells. Int Immunopharmacol 9 (2009) 878-5
9. Sung M.J., Davaatseren M., Kim W., Park S.K., Kim S.H., Hur H.J., et al. Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells. Int Immunopharmacol 9 (2009) 319-2
10. Lin Z., Zhang Y., Zhang Y., Shen H., Hu L., Jiang H., et al. Oleanolic acid derivative NPLC441 potently stimulates glucose transport in 3T3-L1 adipocytes via a multi-target mechanism. Biochem Pharmacol 76 (2008) 1251-1262
11. Chiou G.C., and Liu S.X. Systemic anti-inflammation by synthetic interleukin-1 blockers. Zhongguo Yao Li Xue Bao 20 (1999) 405-408
12. Kim J.H., Jang Y.O., Kim B.T., Hwang K.J., and Lee J.C. Induction of caspase-dependent apoptosis in melanoma cells by a synthetic compound, (E)-1-(3, 4-dihydroxyphenethyl)-3-styrylurea. BMB reports 42 (2009) 806-811
13. Cho KM. in: Chonbuk National University (Eds.; Ph.D thesis), Scavenging effect of acteoside and its synthetic analogs on paraquat-derived reactive oxygen species, Jeonju, South Korea, 2009, pp. 58-74.
14. Seelinger G., Merfort I., and Schempp C.M. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74 (2008) 1667-1677
15. Rathee P., Chaudhary H., Rathee S., Rathee D., Kumar V., and Kohli K. Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets 8 (2009) 229-235
16. Son Y.O., Jang Y.S., Heo J.S., Chung W.T., Choi K.C., and Lee J.C. Apoptosis-inducing factor plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Apoptosis 14 (2009) 796-808
17. Weissman B.A., and Gross S.S. Measurement of NO and NO synthase. Cur Prot Neurosci (2001) Chapter 7; 13
18. Maulik N., Sato M., Price B.D., and Das D.K. An essential role of NF-kappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 429 (1998) 365-369
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-5
20. Lee J.C., Kim J., Park J.K., Chung G.H., and Jang Y.S. The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Exp Cell Res 291 (2003) 386-397
21. Munhoz C.D., García-Bueno B., Madrigal J.L., Lepsch L.B., Scavone C., and Leza J.C. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res 41 (2008) 1037-1046
22. Nath N., Khan M., Paintlia M.K., Hoda M.N., and Giri S. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 182 (2009) 8005-8014
23. Murakami A. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase. Forum Nutr 61 (2009) 193-203
24. Xagorari A., Roussos C., and Papapetropoulos A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 136 (2002) 1058-1064
25. Kang J.S., Lee K.H., Han M.H., Lee H., Ahn J.M., Han S.B., et al. Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother Res 22 (2008) 883-888
26. Kim J.Y., Shin J.S., Ryu J.H., Kim S.Y., Cho Y.W., Choi J.H., et al. Anti-inflammatory effect of anemarsaponin B isolated from the rhizomes of Anemarrhena asphodeloides in LPS-induced RAW 264.7 macrophages is mediated by negative regulation of the nuclear factor-kappaB and p38 pathways. Food Chem Toxicol 47 (2009) 1610-1617
27. Kang E.H., Gebru E., Kim M.H., Cheng H., and Park S.C. EstA protein, a novel virulence factor of Streptococcus pneumoniae, induces nitric oxide and pro-inflammatory cytokine production in RAW 264.7 macrophages through NF-kappaB/MAPK. Micro Pathog 47 (2009) 196-201
28. Kim Y.W., Zhao R.J., Park S.J., Lee J.R., Cho I.J., Yang C.H., et al. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol 154 (2008) 165-173
29. Yang E.B., Zhang K., Cheng L.Y., and Mack P. Butein, a specific protein tyrosine kinase inhibitor. Biochem Biophys Res Commun 245 (1998) 435-438
30. Gamet-Payrastre L., Manenti S., Gratacap M.P., Tulliez J., Chap H., and Payrastre B. Flavonoids and the inhibition of PKC and PI3-kinase. Gen Pharmacol 32 (1999) 279-286
31. Caltagirone S., Rossi C., Poggi A., Ranelletti F.O., Natali P.G., Brunetti M., et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87 (2000) 595-600
32. Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med 22 (2007) 63-72
33. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor. J Exp Med 189 (1999) 1777-1782
34. Muroi M., Ohnishi T., and Tanamoto K. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappaB. J Biol Chem 277 (2002) 42372-42379
35. Yang H., Young D.W., Gusovsky F., and Chow J.C. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275 (2000) 20861-20866
36. Wang J.X., Hou L.F., Yang Y., Tang W., Li Y., and Zuo J.P. SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages. Acta Pharmacol Sin 30 (2009) 1428-1435